Inhibitory effects of choline-O-sulfate on amyloid formation of human islet amyloid polypeptide

FEBS Open Bio

Volumn 2, Issue , 2012, Pages 20-25

  Hagihara, Mamoru ^a   Takei, Ayaka ^a   Ishii, Takeshi ^a   Hayashi, Fumio ^a   Kubota, Kenji ^a   Wakamatsu, Kaori ^a   Nameki, Nobukazu ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Aggregation inhibitor; Amyloid formation; CD; Choline O sulfate; COS; HFIP; HIAPP; Islet amyloid polypeptide; NDSB; Osmolyte; TEM; ThT

Indexed keywords

2 (TRIMETHYLAMMONIO)ETHYLSULFATE; ACETYLCHOLINE; AMYLIN; AMYLOID; BETAINE; CARNITINE; CHOLINE DERIVATIVE; CHOLINE O SULFATE; NDSB 195; NDSB 201; NDSB 211; NDSB 221; NDSB 256; NON DETERGENT SULFOBETAINE DERIVATIVE; THIOFLAVINE; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; BETA SHEET; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; FLUORESCENCE ANALYSIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; TRANSMISSION ELECTRON MICROSCOPY;

ALGAE; BACTERIA (MICROORGANISMS); FUNGI;

EID: 84861212656     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2012.02.001     Document Type: Article

References (45)

1. Kumar R. Role of naturally occurring osmolytes in protein folding and stability. Arch. Biochem. Biophys. 2009, 491:1-6.
2. Caldas T., Demont-Caulet N., Ghazi A., Richarme G. Thermoprotection by glycine betaine and choline. Microbiology 1999, 145(Pt 9):2543-2548.
3. Knapp S., Ladenstein R., Galinski E.A. Extrinsic protein stabilization by the naturally occurring osmolytes β-hydroxyectoine and betaine. Extremophiles 1999, 3:191-198.
4. Diamant S., Eliahu N., Rosenthal D., Goloubinoff P. Chemical chaperones regulate molecular chaperones in vitro and in cells under combined salt and heat stresses. J. Biol. Chem. 2001, 276:39586-39591.
5. Baskaran N., Kandpal R.P., Bhargava A.K., Glynn M.W., Bale A., Weissman S.M. Uniform amplification of a mixture of deoxyribonucleic acids with varying GC content. Genome Res. 1996, 6:633-638.
6. Hengen P.N. Optimizing multiplex and LA-PCR with betaine. Trends Biochem. Sci. 1997, 22:225-226.
7. Henke W., Herdel K., Jung K., Schnorr D., Loening S.A. Betaine improves the PCR amplification of GC-rich DNA sequences. Nucleic Acids Res. 1997, 25:3957-3958.
8. Weissensteiner T., Lanchbury J.S. Strategy for controlling preferential amplification and avoiding false negatives in PCR typing. Biotechniques 1996, 21:1102-1108.
9. Natalello A., Liu J., Ami D., Doglia S.M., de Marco A. The osmolyte betaine promotes protein misfolding and disruption of protein aggregates. Proteins 2009, 75:509-517.
10. Singh L.R., Poddar N.K., Dar T.A., Kumar R., Ahmad F. Protein and DNA destabilization by osmolytes: the other side of the coin. Life Sci. 2011, 88:117-125.
11. Liu R., Barkhordarian H., Emadi S., Park C.B., Sierks M.R. Trehalose differentially inhibits aggregation and neurotoxicity of β-amyloid 40 and 42. Neurobiol. Dis. 2005, 20:74-81.
12. Ryu J., Kanapathipillai M., Lentzen G., Park C.B. Inhibition of β-amyloid peptide aggregation and neurotoxicity by α-d-mannosylglycerate, a natural extremolyte. Peptides 2008, 29:578-584.
13. Kanapathipillai M., Lentzen G., Sierks M., Park C.B. Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's β-amyloid. FEBS Lett. 2005, 579:4775-4780.
14. Rajan R.S., Tsumoto K., Tokunaga M., Tokunaga H., Kita Y., Arakawa T. Chemical and pharmacological chaperones: application for recombinant protein production and protein folding diseases. Curr. Med. Chem. 2011, 18:1-15.
15. Catalfomo P., Block J.H., Constantine G.H., Kirk P.W. Choline sulfate (ester) in marine higher fungi. Mar. Chem. 1972, 1:157-162.
16. Fitzgerald J.W., Luschinski P.C. Further studies on the formation of choline sulfate by bacteria. Can. J. Microbiol. 1977, 23:483-490.
17. Hanson A.D., Gage D.A. Identification and determination by fast atom bombardment mass spectrometry of the compatible solute choline-O-sulphate in Limonium species and other halophytes. Aust. J. Plant Physiol. 1991, 18:317-327.
18. Hanson A.D., Rathinasabapathi B., Chamberlin B., Gage D.A. Comparative physiological evidence that β-alanine betaine and choline-O-sulfate act as compatible osmolytes in halophytic Limonium species. Plant Physiol. 1991, 97:1199-1205.
19. Hanson A.D., Rathinasabapathi B., Rivoal J., Burnet M., Dillon M.O., Gage D.A. Osmoprotective compounds in the Plumbaginaceae: a natural experiment in metabolic engineering of stress tolerance. Proc. Natl. Acad. Sci. USA 1994, 91:306-310.
20. Markham P., Robson G.D., Bainbridge B.W., Trinci A.P. Choline: its role in the growth of filamentous fungi and the regulation of mycelial morphology. FEMS Microbiol. Rev. 1993, 10:287-300.
21. Cánovas D., Vargas C., Csonka L.N., Ventosa A., Nieto J.J. Osmoprotectants in Halomonas elongata: high-affinity betaine transport system and choline-betaine pathway. J. Bacteriol. 1996, 178:7221-7226.
22. Gutierrez J.A., Csonka L.N. Isolation and characterization of adenylate kinase (adk) mutations in Salmonella typhimurium which block the ability of glycine betaine to function as an osmoprotectant. J. Bacteriol. 1995, 177:390-400.
23. Park Y.I., Gander J.E. Choline derivatives involved in osmotolerance of Penicillium fellutanum. Appl. Environ. Microbiol. 1998, 64:273-278.
24. Khemtemourian L., Killian J.A., Hoppener J.W., Engel M.F. Recent insights in islet amyloid polypeptide-induced membrane disruption and its role in β-cell death in type 2 diabetes mellitus. Exp. Diabetes Res. 2008, 2008:421287.
25. Westermark P., Andersson A., Westermark G.T. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol. Rev. 2011, 91:795-826.
26. Vuillard L., Braun-Breton C., Rabilloud T. Non-detergent sulphobetaines: a new class of mild solubilization agents for protein purification. Biochem. J 1995, 305(Pt 1):337-343.
27. Expert-Bezançon N., Rabilloud T., Vuillard L., Goldberg M.E. Physical-chemical features of non-detergent sulfobetaines active as protein-folding helpers. Biophys. Chem. 2003, 100:469-479.
28. Xiang L., Ishii T., Hosoda K., Kamiya A., Enomoto M., Nameki N., Inoue Y., Kubota K., Kohno T., Wakamatsu K. Interaction of anti-aggregation agent dimethylethylammonium propane sulfonate with acidic fibroblast growth factor. J. Magn. Reson. 2008, 194:147-151.
29. Higham C.E., Jaikaran E.T., Fraser P.E., Gross M., Clark A. Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils. FEBS Lett. 2000, 470:55-60.
30. Arora A., Ha C., Park C.B. Inhibition of insulin amyloid formation by small stress molecules. FEBS Lett. 2004, 564:121-125.
31. Sreerama N., Venyaminov S.Y., Woody R.W. Estimation of protein secondary structure from circular dichroism spectra: inclusion of denatured proteins with native proteins in the analysis. Anal. Biochem. 2000, 287:243-251.
32. Sreerama N., Woody R.W. Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal. Biochem. 2000, 287:252-260.
33. Goldsbury C., Kistler J., Aebi U., Arvinte T., Cooper G.J. Watching amyloid fibrils grow by time-lapse atomic force microscopy. J. Mol. Biol. 1999, 285:33-39.
34. Goldsbury C.S., Cooper G.J., Goldie K.N., Muller S.A., Saafi E.L., Gruijters W.T., Misur M.P., Engel A., Aebi U., Kistler J. Polymorphic fibrillar assembly of human amylin. J. Struct. Biol. 1997, 119:17-27.
35. Kayed R., Bernhagen J., Greenfield N., Sweimeh K., Brunner H., Voelter W., Kapurniotu A. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J. Mol. Biol. 1999, 287:781-796.
36. Biancalana M., Koide S. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim. Biophys. Acta. 2010, 1804:1405-1412.
37. 2-microglobulin into amyloid. J. Mol. Biol. 2005, 351:850-864.
38. Nielsen L., Khurana R., Coats A., Frokjaer S., Brange J., Vyas S., Uversky V.N., Fink A.L. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 2001, 40:6036-6046.
39. Goldsbury C., Goldie K., Pellaud J., Seelig J., Frey P., Muller S.A., Kistler J., Cooper G.J., Aebi U. Amyloid fibril formation from full-length and fragments of amylin. J. Struct. Biol. 2000, 130:352-362.
40. Porat Y., Mazor Y., Efrat S., Gazit E. Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions. Biochemistry 2004, 43:14454-14462.
41. Arakawa T., Timasheff S.N. The stabilization of proteins by osmolytes. Biophys. J. 1985, 47:411-414.
42. Timasheff S.N. Protein-solvent preferential interactions, protein hydration, and the modulation of biochemical reactions by solvent components. Proc. Natl. Acad. Sci. USA 2002, 99:9721-9726.
43. Auton M., Bolen D.W. Additive transfer free energies of the peptide backbone unit that are independent of the model compound and the choice of concentration scale. Biochemistry 2004, 43:1329-1342.
44. Liu Y., Bolen D.W. The peptide backbone plays a dominant role in protein stabilization by naturally occurring osmolytes. Biochemistry 1995, 34:12884-12891.
45. Bolen D.W., Baskakov I.V. The osmophobic effect: natural selection of a thermodynamic force in protein folding. J. Mol. Biol. 2001, 310:955-963.